NantOmics

NantOmics

Cloud-based molecular profiling tools that help guide cancer patients.
  • Edit
DateInvestorsAmountRound

$250m

Valuation: $1.5b

Series A
Total FundingCAD341m

Recent News about NantOmics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by NantOmics

Edit
Genos
ACQUISITION by NantOmics Apr 2017
OncoPlexDx
ACQUISITION by NantOmics Sep 2015